Literature DB >> 4867739

Agar medium for the selective enumeration of coagulase-positive Staphylococcus from the rat alimentary tract.

A B Dickinson, P Raibaud, G Mocquot.   

Abstract

A selective agar medium (medium J(1)) is proposed for the quantitative enumeration of egg yolk-positive (EYP) and egg yolk-negative (EYN) Staphylococcus pyogenes from the digestive tract and feces of the rat. This medium, buffered at pH 5.0, is composed of acid casein hydrolysate and yeast extract with 7.5% sodium chloride, 1.6% sodium pyruvate, 0.0008% 2,3,5-triphenyltetrazolium chloride (TTC), and 6% egg yolk emulsion. Inoculation is by the pour-plate method and incubation is at 38 C in a water-jacketed incubator for 36 hr. Colonies of S. pyogenes reduce TTC; EYP strains are surrounded by a halo of opacity; and EYN strains may be surrounded by a red halo, but no opacity. Small, white colonies of S. epidermidis may develop, but Micrococcus, and all other groups of Staphylococcus recognized in the rat intestinal flora, are inhibited. Other bacterial genera, notably Bacillus, Corynebacterium, Proteus, and Streptococcus, are also inhibited.

Entities:  

Mesh:

Substances:

Year:  1968        PMID: 4867739      PMCID: PMC252034          DOI: 10.1128/jb.95.2.418-425.1968

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  23 in total

1.  IMPROVED STAPHYLOCOCCUS MEDIUM NO. 110.

Authors:  S A SMUCKLER; M D APPLEMAN
Journal:  Appl Microbiol       Date:  1964-07

2.  Staphylococcal lipolysis and pigmentation.

Authors:  A T WILLIS; G C TURNER
Journal:  J Pathol Bacteriol       Date:  1962-10

3.  [Influence of pH on the enzymatic activity of Staphylococcus in egg yolk media. I. Behavior on solid media].

Authors:  A PERNICE; N MACRI
Journal:  G Batteriol Virol Immunol       Date:  1962 Jul-Aug

4.  A study of the staphylococci associated with the bovine udder.

Authors:  W B REID; J B WILSON
Journal:  Am J Vet Res       Date:  1959-09       Impact factor: 1.156

5.  Some properties of Staphylococcus aureus, possibly related to pathogenicity. Part 2. In-vitro properties and origin of the infecting strains correlated to mortality in 190 patients with Staphylococcus aureus bacteremia.

Authors:  O JESSEN; V FABER; K ROSENDAL; K R ERIKSEN
Journal:  Acta Pathol Microbiol Scand       Date:  1959

6.  Some cultural characteristics of Staphylococcus aureus strains from superficial skin infections.

Authors:  M T PARKER
Journal:  J Hyg (Lond)       Date:  1958-06

7.  Production of opacity in egg-yolk broth by Staphylococci from various sources.

Authors:  V G ALDER; W A GILLESPIE; G HERDAN
Journal:  J Pathol Bacteriol       Date:  1953-07

8.  A comparative study of known food-poisoning staphylococci and related varieties.

Authors:  J B EVANS; C F NIVEN
Journal:  J Bacteriol       Date:  1950-04       Impact factor: 3.490

9.  EGG YOLK FACTOR OF STAPHYLOCOCCUS AUREUS. I. NATURE OF THE SUBSTRATE AND ENZYME INVOLVED IN THE EGG YOLK OPACITY REACTION.

Authors:  D B SHAH; J B WILSON
Journal:  J Bacteriol       Date:  1963-03       Impact factor: 3.490

10.  [Microflora of the rat digestive tract. IV. Controlled implantation in gnotobiotic rats of various microbial genera isolated from conventional rats].

Authors:  P Raibaud; A B Dickinson; E Sacquet; H Charlier; G Mocquot
Journal:  Ann Inst Pasteur (Paris)       Date:  1966-08
View more
  3 in total

1.  Lysogenic conversion for multiple characters in a strain of Staphylococcus aureus.

Authors:  Y Duval-Iflah; J Van Heijenoort; M Rousseau; P Raibaud
Journal:  J Bacteriol       Date:  1977-06       Impact factor: 3.490

2.  beta-Glucuronidase activities of intestinal bacteria determined both in vitro and in vivo in gnotobiotic rats.

Authors:  D Gadelle; P Raibaud; E Sacquet
Journal:  Appl Environ Microbiol       Date:  1985-03       Impact factor: 4.792

3.  Mechanism of bacteriophage conversion of lipase activity in Staphylococcus aureus.

Authors:  C Y Lee; J J Iandolo
Journal:  J Bacteriol       Date:  1985-10       Impact factor: 3.490

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.